合成幹細胞の世界市場 (〜2028年)：心血管疾患・神経系疾患・その他 (癌・糖尿病・消化器疾患・筋骨格障害)
Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America, Europe, APAC, RoW) - Global Forecast to 2028
|出版日||ページ情報||英文 55 Pages
|合成幹細胞の世界市場 (〜2028年)：心血管疾患・神経系疾患・その他 (癌・糖尿病・消化器疾患・筋骨格障害) Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America, Europe, APAC, RoW) - Global Forecast to 2028|
|出版日: 2018年12月05日||ページ情報: 英文 55 Pages||
世界の合成幹細胞の市場は予測期間中22.5%のCAGR (年間複合成長率) で推移し、2023年の1350万米ドルから、2028年には3720万米ドルの規模に成長すると予測されています。胚性幹細胞に関する倫理上の懸念、腫瘍形成や天然幹細胞の免疫による拒絶反応のリスクなどの要因が同市場の成長を推進しています。しかし一方で、不明確で体系化されていない合成幹細胞の利用に関する法規制が同市場のさらなる成長の障壁となっています。
"Ethical concerns regarding embryonic stem cells is expected to drive the overall growth of the synthetic stem cells market."
The synthetic stem cells market is expected to grow from USD 14 million in 2023 to USD 37 million by 20283, at a CAGR of 22.5% during the forecast period. The synthetic stem cells market is driven by various factors such as ethical concerns regarding embryonic stem cells and the risk of tumor formation and immune rejection of natural stem cells. However, the unclear and unstructured regulations on the use of synthetic stem cells can hinder the growth of the market.
The neurological disorders application is the faster-growing segment in the overall synthetic stem cells market. Based on application, the synthetic stem cells market is segmented into cardiovascular diseases, neurological disorders, and other diseases that include various cancers, wounds and injuries, musculoskeletal disorders, and blood disorders that require regenerative therapies.
Countries in North America are constantly modernizing their healthcare infrastructure by investing in advanced therapies. The increasing prevalence of target diseases, focus on development of for regenerative medicines, fast adoption of advanced therapies, and regulatory support for stem cell therapies will result in the high rate of adoption of synthetic stem cell therapies in this region by 2023.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, innovation and technology directors, and executives from various key organizations operating in the synthetic stem cells market.
The synthetic stem cells market comprises two major providers, namely, North Carolina State University (NCSU) (US) and Zhengzhou University (China).
This market study covers the synthetic stem cells market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on application and region.
The report will provide the market leaders/new entrants in this market with information on the closest approximations of the revenue of the overall synthetic stem cells market and its subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report will also help stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.